The global triamcinolone ointment chlorofluorocarbons market is expected to grow at a significant CAGR during the forecast period (2021-2027). Skin disease affects millions of people across the globe and is one of the primary causes of the rising global disease burden. Triamcinolone is a drug that is used to treat inflammation in a variety of diseases such as allergic responses, eczema, and psoriasis. A variety of skin diseases are caused by ageing, environmental causes, and genetic factors. As people become older the chance of having skin-related disorders increases owing to the factors such as changes in connective tissue, a decrease in the skin's firmness and elasticity, and a decrease in sebaceous gland secretions. As a result, the market is expected to be driven by increased incidences of skin disease.

The market is segmented into eczema, dermatitis, allergies, psoriasis, and others based on application. Triamcinolone acts by relaxing hyperactive immune systems and decreasing inflammation. It lowers the swelling, itching, and redness caused by allergies and can be used for a short or long time, depending on the severity of the condition. According to the British Society for Allergy and Clinical Immunology (BSACI), the prevalence of diseases such as allergic rhinitis, asthma, and eczema is quite high in the UK, which is expected to drive the demand for triamcinolone ointment chlorofluorocarbons during the forecast period.

Additionally, owing to the increased awareness of skin problems, and the presence of big firms, North America holds a potential share in the global triamcinolone ointment chlorofluorocarbons market. In the US, a growing number of skin cancer cases have been discovered. According to the American Cancer Society, nearly 6,850 persons in the US are anticipated to die of melanoma in 2020. Furthermore, owing to the rising prevalence of dermatological disease, the global triamcinolone ointment chlorofluorocarbons market is expected to grow during the forecast period.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Bristol Myers Squibb Co., Glenmark Pharmaceuticals Inc., and Lupin Ltd, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Triamcinolone Ointment Chlorofluorocarbons Market Report by Segment

 By Application 

• Eczema

• Dermatitis

• Allergies

• Psoriasis

• Others

Global Triamcinolone Ointment Chlorofluorocarbons Market by region